Campbell & Co Investment Adviser’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $945K | Sell |
43,541
-51,538
| -54% | -$1.12M | 0.06% | 527 |
|
|
2025
Q1 | $2.31M | Buy |
+95,079
| New | +$2.31M | 0.18% | 155 |
|
|
2024
Q2 | – | Sell |
-19,202
| Closed | -$306K | – | 1086 |
|
|
2024
Q1 | $306K | Buy |
+19,202
| New | +$306K | 0.03% | 897 |
|
|
2023
Q2 | – | Sell |
-31,721
| Closed | -$526K | – | 924 |
|
|
2023
Q1 | $526K | Sell |
31,721
-28,188
| -47% | -$467K | 0.1% | 399 |
|
|
2022
Q4 | $1.11M | Sell |
59,909
-12,653
| -17% | -$235K | 0.27% | 80 |
|
|
2022
Q3 | $931K | Sell |
72,562
-81,805
| -53% | -$1.05M | 0.21% | 144 |
|
|
2022
Q2 | $1.08M | Buy |
154,367
+18,986
| +14% | +$133K | 0.29% | 65 |
|
|
2022
Q1 | $1.12M | Buy |
135,381
+59,181
| +78% | +$490K | 0.3% | 61 |
|
|
2021
Q4 | $516K | Buy |
76,200
+44,500
| +140% | +$301K | 0.18% | 188 |
|
|
2021
Q3 | $168K | Sell |
31,700
-11,200
| -26% | -$59.4K | 0.05% | 540 |
|
|
2021
Q2 | $247K | Buy |
+42,900
| New | +$247K | 0.1% | 381 |
|